TAK-243

产品说明书

Print
Chemical Structure| 1450833-55-2 同义名 : MLN7243
CAS号 : 1450833-55-2
货号 : A677503
分子式 : C19H20F3N5O5S2
纯度 : 99%+
分子量 : 519.52
MDL号 : MFCD28964160
存储条件:

Pure form Keep in dark place, sealed in dry, 2-8°C

In solvent -20°C:3-6个月-80°C:12个月

溶解度 : -
动物实验配方:
生物活性
描述 Ubiquitin activating enzyme (UAE) is a key enzyme responsible for ubiquitin conjugation in mammals. TAK-243 is a potent, small-molecule inhibitor of UAE with an IC50 value of 1 ± 0.2 nM. In HCT-116 cells, treatment with TAK-243 (0.01 - 1μΜ) dose-dependently reduced both polyubiquitin chains and mono-ubiquitylated histone H2B without affecting UAE protein levels. TAK-243 treatment also led to an accumulation of short-lived proteins, such as c-Jun, c-Myc, MCL1 and p53. In TAK-243-treated HCT-116 cells, a complete G2/M arrest was observed at the concentration of 0.05 μΜ. TAK-243 (0.01 - 1 μΜ) also induced the phosphorylation of kinase PERK, endoplasmic reticulum to nucleus signaling 1, and the accumulation of activating transcription factor 6. In Calu-6 cells, one-hour pretreatment of TAK-243 (1 μΜ) followed by UV irradiation resulted in persistent, unresolved DNA damage. TAK-243 showed an anti-proliferative effect in a panel of human cancer cell lines with variable EC50 values ranging from 0.006 to 1.31 μΜ. In mice bearing xenograft tumors (i.e. CWR22, SWU-DLCL2, and PHTX-132Lu) intravenous administration with TAK-243 (25 mg/kg/dose, 2 doses/week, 3 weeks) induced a robust antitumor activity response with tumor growth inhibition values ranging from 83 to 97[1].
作用机制 TAK-243 inhibits the catalytic activity of UAE via the formation of a TAK-243-ubiquitin adduct.
实验方案
1mg 5mg 10mg

1 mM

5 mM

10 mM

1.92mL

0.38mL

0.19mL

9.62mL

1.92mL

0.96mL

19.25mL

3.85mL

1.92mL

参考文献

[1]Hyer ML, Milhollen MA, Ciavarri J, Fleming P, Traore T, Sappal D, Huck J, Shi J, Gavin J, Brownell J, Yang Y, Stringer B, Griffin R, Bruzzese F, Soucy T, Duffy J, Rabino C, Riceberg J, Hoar K, Lublinsky A, Menon S, Sintchak M, Bump N, Pulukuri SM, Langston S, Tirrell S, Kuranda M, Veiby P, Newcomb J, Li P, Wu JT, Powe J, Dick LR, Greenspan P, Galvin K, Manfredi M, Claiborne C, Amidon BS, Bence NF. A small-molecule inhibitor of the ubiquitin activating enzyme for cancer treatment. Nat Med. 2018 Feb;24(2):186-193. doi: 10.1038/nm.4474. Epub 2018 Jan 15. PMID: 29334375.